Registration Statement No. 333-275898
Filed Pursuant to Rule 433
| AUTOCALLABLE STRATEGIC ACCELERATED REDEMPTION SECURITIES® (STARS®) |
| Autocallable Strategic Accelerated Redemption Securities® Linked to the State Street® SPDR® S&P® Biotech ETF |
| Issuer | Royal Bank of Canada (“RBC”). References on this page to “we,” “us” or “our” mean RBC. |
| Principal Amount | $10.00 per unit |
| Term | Approximately 3 years, if not called on the first or second Observation Dates |
| Market Measure | The State Street® SPDR® S&P® Biotech ETF (Bloomberg symbol: “XBI”) |
| Automatic Call | Automatic call if the Observation Level of the Market Measure on any of the Observation Dates is equal to or greater than the Starting Value |
| Observation Level | The Closing Market Price of the Market Measure on any Observation Date times its Price Multiplier as of that day |
| Observation Dates | Approximately one, two and three years after the pricing date |
| Call Amounts |
In the event of an automatic call, the amount payable per unit will be: · [$11.25 to $11.35] if called on the first Observation Date · [$12.50 to $12.70] if called on the second Observation Date · [$13.75 to $14.05] if called on the final Observation Date, each to be determined on the pricing date |
| Threshold Value | 100% of the Starting Value |
| Payout Profile at Maturity | If not called, 1-to-1 downside exposure to decreases in the Market Measure, with 100% of your principal at risk |
| Preliminary Offering Documents | https://www.sec.gov/Archives/edgar/data/1000275/000095010326001192/dp240574_424b2-mlaqe.htm |
| Exchange Listing | No |
|
You should read the relevant Preliminary Offering Documents before you invest. Click on the Preliminary Offering Documents hyperlink above or call your Financial Advisor for a hard copy. Risk Factors Please see the Preliminary Offering Documents for a description of certain risks related to this investment, including, but not limited to, the following: |
| · | If the notes are not automatically called, your investment will result in a loss; there is no guaranteed return of principal. |
| · | Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity. |
| · | Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. |
| · | Your investment return is limited to the return represented by the applicable Call Premium and may be less than a comparable investment directly in shares of the Market Measure or the securities held by the Market Measure. |
| · | The initial estimated value of the notes is only an estimate, determined as of a particular point in time by reference to our and our affiliates’ pricing models. |
| · | The public offering price you pay for the notes will exceed the initial estimated value. |
| · | The initial estimated value does not represent a minimum or maximum price at which we, MLPF&S, BofAS or any of our affiliates would be willing to purchase your notes in any secondary market (if any exists) at any time. |
| · | A trading market is not expected to develop for the notes. |
| · | Our business, hedging and trading activities, and those of MLPF&S, BofAS and our respective affiliates (including trades in shares of the Market Measure or the securities held by the Market Measure), and any hedging and trading activities we, MLPF&S, BofAS or our respective affiliates engage in for our clients’ accounts, may affect the market value and return of the notes and may create conflicts of interest with you. |
| · | There may be potential conflicts of interest involving the calculation agent, which is BofAS. |
| · | The sponsor and advisor of the Market Measure may adjust the Market Measure in a way that could adversely affect the value of the notes and the amount payable on the notes, and these entities have no obligation to consider your interests. |
| · | You will have no rights of a holder of shares of the Market Measure or the securities held by the Market Measure, and you will not be entitled to receive securities or dividends or other distributions by the issuers of those securities. |
| · | While we, MLPF&S, BofAS or our respective affiliates may from time to time own shares of the Market Measure or the securities held by the Market Measure, we, MLPF&S, BofAS and our respective affiliates do not control the Market Measure or the issuers of those securities, and have not verified any disclosure made by any other company. |
| · | There are liquidity and management risks associated with the Market Measure. |
| · | The performance of the Market Measure may not correlate with the performance of the securities held by the Market Measure as well as the net asset value per share of the Market Measure, especially during periods of market volatility when the liquidity and the market price of shares of the Market Measure and/or the securities held by the Market Measure may be adversely affected, sometimes materially. |
| · | The payment on the notes will not be adjusted for all corporate events that could affect the Market Measure. |
| · | The U.S. federal income tax consequences of an investment in the notes are uncertain. |
| · | The securities held by the Market Measure are concentrated in one industry. |
| · | Adverse conditions in the biotechnology industry may reduce your return on the notes. |
| Final terms will be set on the pricing date within the given range for the specified Market-Linked Investment. Please see the Preliminary Offering Documents for complete product disclosure, including related risks and tax disclosure. |
RBC has filed a registration statement (including a product supplement, a prospectus supplement and a prospectus) with the SEC for the offering to which this document relates. Before you invest, you should read those documents, and the other documents that RBC has filed with the SEC, for more complete information about RBC and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, RBC, any agent, or any dealer participating in this offering will arrange to send you these documents if you so request by calling toll-free 1-800-294-1322.